EcoR1 Capital Fund Qualified, L.P.

EcoR1 Capital Fund Qualified, L.P. is a declared insider of Lakefront Biotherapeutics, with filings sourced from FSMA. Over a trading history stretching from 13 May 2025 to 28 July 2025, the count stands at 16 filings.

Every open-market trade on record is a purchase: 16 purchases worth €42.6M, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

The median purchase comes to €2.1M. Clusters matter here: 16 out of 16 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster. Looking at 16 purchases old enough to measure, the stock rose over the following 90 days in 94% of cases; the median change was +6.9%. This is a record of the past, not a forecast.

On 31 July 2025 came the latest disclosure, an open-market purchase for €3.0M in Lakefront Biotherapeutics. Typically, a trade is published a median of 6 days after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade. Every figure here comes from the filings published by FSMA and describes the past, not future prices; it is not investment advice.